Crop science giant Bayer says it has settled 17,000 glyphosate cases so far and hopes for a supreme court ruling next year.

Bayer has recently settled thousands of cases over claims the active ingredient in its Roundup weedkiller causes cancer, ...

Heading into the second half of their 2025 financial year, Bayer leaders echo positive comments surrounding the company’s ...

The German giant has already trimmed more than 10,000 employees since initiating a massive restructuring initiative in July ...

Investor concerns that Bayer's earnings were inflated by soccer player transfer fees rather than supported by its core ...

Bayer Aktiengesellschaft boosted 2025 sales outlook with pharma growth and lower litigation costs. Click for why BAYRY is an ...

The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...

PROFIT FORECAST: The German pharmaceutical and agricultural conglomerate pre-released preliminary second-quarter numbers last week, announcing group earnings before interest, tax, depreciation, ...

German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 ...

Bayer (BAYRY) stock gains as the company raises 2025 financial outlook, citing strong pharma performance. Read more here.

Bayer has applied for approval in the EU of its new herbicide, icafolin, following applications in Brazil, the US, and Canada ...

Bayer to pay up to $10 billion to settle cancer lawsuits over glyphosate, the herbicide in Roundup The trial included the testimony of thousands of people who got cancer after using Roundup ...